Literature DB >> 16023556

Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome.

Kenji Kurosawa1, Hiroshi Kawame, Nobuhiko Okamoto, Yukikatsu Ochiai, Akira Akatsuka, Masahisa Kobayashi, Masayuki Shimohira, Seiji Mizuno, Kazuko Wada, Yoshimitsu Fukushima, Hisashi Kawawaki, Toshiyuki Yamamoto, Mitsuo Masuno, Kiyoshi Imaizumi, Yoshikazu Kuroki.   

Abstract

The 1p36 deletion syndrome is a newly delineated multiple congenital anomalies/mental retardation syndrome characterized by mental retardation, growth delay, epilepsy, congenital heart defects, characteristic facial appearance, and precocious puberty. We analyzed 11 patients by fluorescence in situ hybridization (FISH) using commercially available bacterial artificial chromosome and P1-derived artificial chromosome genomic clones to define the chromosomal deletion responsible for the 1p36 deletion syndrome. Cytogenetic investigation revealed two cases with a terminal deletion of 1p36. Nine patients had an apparently normal karyotype with standard G-bands by trypsin using Giemsa (GTG), but FISH screening with the highly polymorphic genetic marker D1Z2, which is mapped to 1p36.3 and contains an unusual reiterated 40-bp variable number tandem repeat, revealed a submicroscopic deletion. All patients had severe to profound mental retardation. Based on the University of California Santa Cruz Genome Browser, we constructed a deletion map and analyzed the relationship between neurological findings and chromosomal deletions for the 11 cases. Six cases had intractable epilepsy and three had no seizures. The common deletion interval was about 1 million base pairs (Mbp) located between RP11-82D16 and RP4-785P20 (Rho guanine exchange factor (GEF) 16). The severity of clinical symptoms correlates with the size of the deletion. This is demonstrated by the 3 patients with at least 8Mbp deletions that display profound mental retardation and congenital heart defects. Although haploinsufficiency of the potassium channel beta-subunit (KCNAB2) is thought to be responsible for intractable seizures in the 1p36 deletion syndrome, this was not the case for 3 of the 11 patients in this study. Further investigation of the 1p36 region is necessary to allow identification of genes responsible for the 1p36 deletion syndrome.

Entities:  

Mesh:

Year:  2005        PMID: 16023556     DOI: 10.1016/j.braindev.2005.02.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  12 in total

Review 1.  Trafficking mechanisms underlying neuronal voltage-gated ion channel localization at the axon initial segment.

Authors:  Helene Vacher; James S Trimmer
Journal:  Epilepsia       Date:  2012-12       Impact factor: 5.864

2.  Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability.

Authors:  John J Perkowski; Geoffrey G Murphy
Journal:  J Neurosci       Date:  2011-01-05       Impact factor: 6.167

Review 3.  Clinical review of genetic epileptic encephalopathies.

Authors:  Grace J Noh; Y Jane Tavyev Asher; John M Graham
Journal:  Eur J Med Genet       Date:  2012-01-25       Impact factor: 2.708

Review 4.  Epilepsy and chromosomal abnormalities.

Authors:  Giovanni Sorge; Anna Sorge
Journal:  Ital J Pediatr       Date:  2010-05-03       Impact factor: 2.638

5.  Subtelomeric FISH analysis in 76 patients with syndromic developmental delay/intellectual disability.

Authors:  Elga F Belligni; Elisa Biamino; Cristina Molinatto; Jole Messa; Mauro Pierluigi; Francesca Faravelli; Orsetta Zuffardi; Giovanni B Ferrero; Margherita Cirillo Silengo
Journal:  Ital J Pediatr       Date:  2009-04-27       Impact factor: 2.638

6.  Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells.

Authors:  M M Suhoski; E E Perez; M L Heltzer; A Laney; L G Shaffer; S Saitta; S Nachman; N B Spinner; C H June; J S Orange
Journal:  Clin Immunol       Date:  2008-06-03       Impact factor: 3.969

7.  Neuropathology of brain and spinal malformations in a case of monosomy 1p36.

Authors:  Naoko Shiba; Ray A M Daza; Lisa G Shaffer; A James Barkovich; William B Dobyns; Robert F Hevner
Journal:  Acta Neuropathol Commun       Date:  2013-08-02       Impact factor: 7.801

8.  1p36 deletion syndrome confirmed by fluorescence in situ hybridization and array-comparative genomic hybridization analysis.

Authors:  Dong Soo Kang; Eunsim Shin; Jeesuk Yu
Journal:  Korean J Pediatr       Date:  2016-11-30

9.  Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype.

Authors:  Stefano Stagi; Elisabetta Lapi; Marilena Pantaleo; Francesco Chiarelli; Salvatore Seminara; Maurizio de Martino
Journal:  BMC Med Genet       Date:  2014-01-30       Impact factor: 2.103

10.  Central precocious puberty in a 3 year-old girl with Phenylketonuria: a rare association?

Authors:  Laura Lucaccioni; Bernd C Schwahn; Malcolm Donaldson; Claudio Giacomozzi
Journal:  BMC Endocr Disord       Date:  2014-04-28       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.